SJS Investment Consulting’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
SJS Investment Consulting's AMGN Position: Q2 2026 in Review
SJS Investment Consulting reduced its Amgen (AMGN) stake by 0.3% in Q2 2026, selling an estimated $685 and leaving 657 shares worth $238K. The position accounts for 0.03% of the portfolio, ranked #148.
SJS Investment Consulting first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $249K in Q4 2025. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- SJS Investment Consulting held 657 shares of Amgen worth $238K as of Q2 2026.
- SJS Investment Consulting sold 2 Amgen shares in Q2 2026, an estimated $685.
- Amgen made up 0.03% of SJS Investment Consulting's portfolio in Q2 2026, its #148 holding.
- SJS Investment Consulting first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
- SJS Investment Consulting's Amgen position peaked at $249K in Q4 2025.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.